These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 10070877

  • 1. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
    Hu XF, Slater A, Rischin D, Kantharidis P, Parkin JD, Zalcberg J.
    Br J Cancer; 1999 Feb; 79(5-6):831-7. PubMed ID: 10070877
    [Abstract] [Full Text] [Related]

  • 2. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
    Bhat UG, Winter MA, Pearce HL, Beck WT.
    Mol Pharmacol; 1995 Oct; 48(4):682-9. PubMed ID: 7476894
    [Abstract] [Full Text] [Related]

  • 3. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C, Goubin F, Ferrandis E, Cornil-Scharwtz I, Bailly JD, Bordier C, Bénard J, Sikic BI, Laurent G.
    Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
    [Abstract] [Full Text] [Related]

  • 4. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporin A and PSC 833 prevent up-regulation of MDR1 expression by anthracyclines in a human multidrug-resistant cell line.
    Hu XF, Slater A, Wall DM, Parkin JD, Kantharidis P, Zalcberg JR.
    Clin Cancer Res; 1996 Apr; 2(4):713-20. PubMed ID: 9816222
    [Abstract] [Full Text] [Related]

  • 6. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L, Tong Y, Jin Y, Zhou S, Zhang Y, Yang X, Mao N.
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [Abstract] [Full Text] [Related]

  • 7. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.
    Hu XF, Slater A, Wall DM, Kantharidis P, Parkin JD, Cowman A, Zalcberg JR.
    Br J Cancer; 1995 May; 71(5):931-6. PubMed ID: 7734315
    [Abstract] [Full Text] [Related]

  • 8. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M, Komeshima N, Naito M, Isoe T, Otake N, Tsuruo T.
    Cancer Res; 1991 Jan 01; 51(1):157-61. PubMed ID: 1988080
    [Abstract] [Full Text] [Related]

  • 9. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F, Avramis IA, Kwock R, Weinberg KI, Avrami VI.
    Anticancer Res; 2002 Jan 01; 22(3):1361-8. PubMed ID: 12168812
    [Abstract] [Full Text] [Related]

  • 10. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X, Liu T, Gong Y, Zheng B, Meng W, Leng Y.
    Leuk Res; 2009 Aug 01; 33(8):1114-9. PubMed ID: 19036441
    [Abstract] [Full Text] [Related]

  • 11. MRP1 not MDR1 gene expression is the predominant mechanism of acquired multidrug resistance in two prostate carcinoma cell lines.
    Zalcberg J, Hu XF, Slater A, Parisot J, El-Osta S, Kantharidis P, Chou ST, Parkin JD.
    Prostate Cancer Prostatic Dis; 2000 Aug 01; 3(2):66-75. PubMed ID: 12497102
    [Abstract] [Full Text] [Related]

  • 12. Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.
    Hu XF, Slater A, Kantharidis P, Rischin D, Juneja S, Rossi R, Lee G, Parkin JD, Zalcberg JR.
    Blood; 1999 Jun 15; 93(12):4086-95. PubMed ID: 10361105
    [Abstract] [Full Text] [Related]

  • 13. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells.
    Brouillard F, Tondelier D, Edelman A, Baudouin-Legros M.
    Cancer Res; 2001 Feb 15; 61(4):1693-8. PubMed ID: 11245485
    [Abstract] [Full Text] [Related]

  • 14. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004 Feb 15; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 15. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB, Yan ML, Gong JP, Xia RP, Liu LX, Li N, Lu SC, Zhang JG, Zeng DB, Xie JG, Yang JY, Yan LN.
    Chin Med J (Engl); 2007 Apr 20; 120(8):703-7. PubMed ID: 17517188
    [Abstract] [Full Text] [Related]

  • 16. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.
    Weerasinghe P, Hallock S, Tang SC, Trump B, Liepins A.
    Exp Toxicol Pathol; 2006 Aug 20; 58(1):21-30. PubMed ID: 16735106
    [Abstract] [Full Text] [Related]

  • 17. Flow cytometric evaluation of fas expression in relation to response and resistance to anthracyclines in leukemic cells.
    Labroille G, Dumain P, Lacombe F, Belloc F.
    Cytometry; 2000 Mar 01; 39(3):195-202. PubMed ID: 10685076
    [Abstract] [Full Text] [Related]

  • 18. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ, Zhang GZ, Zhao JS, Zhang FC, Bu LS, Yang SJ, Piao SL, Du ZW, Gao S, Zheng DM.
    Chin Med J (Engl); 2005 Jun 05; 118(11):893-902. PubMed ID: 15978189
    [Abstract] [Full Text] [Related]

  • 19. Cytometric study of intracellular P-gp expression and reversal of drug resistance.
    Labroille G, Belloc F, Bilhou-Nabera C, Bonnefille S, Bascans E, Boisseau MR, Bernard P, Lacombe F.
    Cytometry; 1998 Jun 01; 32(2):86-94. PubMed ID: 9627221
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance.
    Quattrone A, Papucci L, Morganti M, Coronnello M, Mini E, Mazzei T, Colonna FP, Garbesi A, Capaccioli S.
    Oncol Res; 1994 Jun 01; 6(7):311-20. PubMed ID: 7865906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.